期刊文献+

Bcl-2shRNA表达载体的构建及其对HL-60细胞生长的抑制作用 被引量:8

Construction of Bcl-2 shRNA expression plasmid and its inhibition on the growth of HL-60 cells
下载PDF
导出
摘要 目的构建Bcl-2短发夹样RNA(shorthairpinRNA,shRNA)序列的表达载体并研究其对HL-60细胞生长的抑制作用。方法化学合成2段编码短发夹RNA序列针对Bcl-2基因66个碱基的寡核苷酸,克隆到Pgenesil-1载体的U6启动子的下游,重组构建RNAi质粒,同时设立阴性对照;然后经酶切电泳和DNA测序鉴定。采用脂质体介导的转染方法将重组的RNAi质粒转入HL-60细胞后,采用RT-PCR检测Bcl-2mRNA表达水平;采用MTT法测定细胞增殖情况。结果重组构建的两个Bcl-2shRNA1、shRNA2载体经双酶切电泳分析及插入基因片段序列分析,结果表明66个碱基成功插入到预期位点,并且序列完全一致。转染Bcl-2shRNA1、shRNA2载体分别入HL-60细胞24h,其Bcl-2mRNA表达水平均降低,但转染Bcl-2shRNA1引起的Bcl-2mRNA表达下降更为明显,分别与转染阴性shRNA及未转染组比较,有显著性差异(P<0.05)。MTT测定显示转染Bcl-2shRNA1、shRNA2载体入HL-60细胞在72、96h细胞生长明显受到抑制,分别与转染阴性shRNA、单纯脂质体组及未转染组比较,差异有显著性(P<0.05)。结论成功地构建了两个Bcl-2shRNA1、shRNA2表达载体,且Bcl-2shRNA可序列特异性地抑制HL-60细胞的生长。 [Objective] To construct expressing vector of short hairpin RNA( shRNA ) targeting Bcl-2,and investigate the effects of Bcl-2 shRNA on the growth of HL-60 cell line. [Methods] Two of 66 base pairs oligonucleotides for short hairpin expression targeting the coding region of Bcl-2 mRNA were designed and were chemically synthesized. Double DNA sequences were obtained through annealing. Pgenesil-1 vector was linearized with BamHⅠ and HindⅢ. Finally, annealed oligonucleotides were inserted into the downstream of treated Pgenesil-1 vector U6 promoter to construct RNAi plasmid. Oligonucleotide with a scrambled sequence was used as negative control. Recombinant expression vector was identified by digestion with PstⅠ and SalⅠ and confirmed by sequencing analysis. Bcl-2 shRNAs were transfected into HL-60 with Lipofectamine. Cytotoxic effects were measured by use of MTY method. The expression levels of Bcl-2 mRNA were assayed by RT-PCR. [Results] Identifying by enzyme cutting and sequencing showed the insertion sequence was correct. Furthermore, 66 bp had been inserted the expected site. RT-PCR assay showed that the expression levels of Bcl-2 mRNA from HL-60 cells decreased after Bcl-2 shRNAs treatment. There was no difference in Bcl-2 mRNA levels between control shRNA and untreated cells. Viable cells at 48, 72 and 96 h after treatment with Bcl-2 shRNAs were less than that after treatment with control shRNAs and untreated HL-60 cells, respectively (P 〈0.05). [Conclusion] Bcl-2 shRNA expression vectors have been constructed successfully, could effectively inhibit the growth of HL-60 cells.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第24期3736-3739,3742,共5页 China Journal of Modern Medicine
基金 广东省自然科学重点基金(编号:021195) 广东省自然科学基金(编号:04010446)资助
关键词 Bcl-2 SHR NA RNAI HL-60细胞 Bcl-2 shRNA RNAi HL-60 cells
  • 相关文献

参考文献12

  • 1ELBASHIR S M, HARBORTH J, LENDECKEL W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature, 2001, 411(6836): 494-498.
  • 2HAMMOND S M, BERNSTEIN E, BEACH D, et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells[J]. Nature, 2000, 404(6775): 293-296.
  • 3NYKANEN A, HALEY B, ZAMORE P D. ATP requirements and small interfering RNA structure in the RNA interference pathway[J]. Cell, 2001, 107(3): 309-321.
  • 4LI K, LIN S Y, BRUNICARDI F C, et al. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma[J]. Cancer Res, 2003, 63(13): 3593-3597.
  • 5PTASZNIK A, NAKATA Y, KALOTA A, et al. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABLI(+) leukemia cells[J]. Nat Med, 2004, 10(11):1187-1189.
  • 6GONDI CS, LAKKA SS, DINH DH, et al. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cellinvasion,angiogenesis and tumor growth in gliomas[J]. Oncogene, 2004, 23(52): 8486-8496.
  • 7VAN DE DONK NW, KAMPHUIS MM, VAN DIIK M, et al.Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein[J]. Leukemia, 2003, 17(1):211-219.
  • 8MARCUCCI G, BYRD JC, DAI G, et al. Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide,in combination with chemotherapy in refractory or relapsed acute leukemia[J]. Blood, 2003, 101(2): 425-432.
  • 9WATERS JS, WEBB A, CUNNINGHAM D, et al. Phase I clinical and phannacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma[J]. J Clin Oncol, 2000, 18(9): 1812-1823.
  • 10ELBASHIR S M, MARTINEZ J, PATKANIOWSKA A, et al.Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate[J]. EMBO J, 2001, 20(23): 6877-6888.

同被引文献41

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部